⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6172695 | 0.72 | — | — | |
| SCHEMBL15259331 | 0.72 | — | — | |
| SCHEMBL16255827 | 0.72 | — | — | |
| SCHEMBL18401894 | 0.65 | — | — | |
| SCHEMBL28355 | 0.61 | — | — | |
| SCHEMBL15547702 | 0.61 | — | — | |
| Lithium Ion SCHEMBL31168143 | 0.61 | — | — | |
| SCHEMBL18485887 | 0.61 | — | — | |
| SCHEMBL2639356 | 0.55 | — | — | |
| SCHEMBL1846761 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016180982-A1 | T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY | ABLYNX N.V. (BE) | 2016-11-17 | — | — | WO | disclosed |